Company / Debt per Share
Amneal Pharmaceuticals, Inc. Debt per Share History
FY2017-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Debt per Share
$14.60
FY2025
5-year range
$14.60 / $20.52
FY2021-FY2025
Trend
-7.6%
vs FY2024
Sector context
#20 of 82
Health Care
What the data says
Amneal Pharmaceuticals, Inc.'s debt per share of $14.60 is higher than 76% of companies in the Health Care sector (FY2025). Debt per Share has declined for 5 consecutive years, from $21.84 in FY2020 to $14.60 in FY2025.
Based on SEC 10-K filings.
14.60 in FY2025 with a 5-year CAGR of -7.7%. Top quartile in the Health Care sector.
Improved from $15.94 to $14.60 over the past 2 years.
Health Care sector context is included.
Debt per Share over time
Growth rates
- 3-Year CAGR
- -6.0%
- 5-Year CAGR
- -7.7%
- 10-Year CAGR
- -
Sector benchmark
-90.4% below sector average
Key checks
Key Insights
- Amneal Pharmaceuticals, Inc.'s debt per share has declined for 5 consecutive years.
- In FY2025, debt per share decreased 7.6% year-over-year.
- Ranks #20 out of 82 companies in the Health Care sector.
- Peak debt per share was recorded in FY2017.
Company context
Key Data Points
- Altman Z-Score 1.22 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Debt per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $14.60 | -7.6% |
| FY2024 | $15.81 | -0.8% |
| FY2023 | $15.94 | -9.5% |
| FY2022 | $17.61 | -14.2% |
| FY2021 | $20.52 | -6.1% |
| FY2020 | $21.84 | +5.7% |
| FY2019 | $20.67 | -0.8% |
| FY2018 | $20.84 | -100.0% |
| FY2017 | $1444445.00 | - |
| FY2016 | - | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026